Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

An Update on Inherited Colon Cancer and Gastrointestinal Polyposis.

Plevová P.

Klin Onkol. 2019 Summer;32(Supplementum2):97-108. doi: 10.14735/amko2019S97.

PMID:
31409085
2.

Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer.

Lin PC, Yeh YM, Wu PY, Hsu KF, Chang JY, Shen MR.

Sci Rep. 2019 Mar 8;9(1):3931. doi: 10.1038/s41598-019-40571-0.

3.

Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status.

Cohen R, Hain E, Buhard O, Guilloux A, Bardier A, Kaci R, Bertheau P, Renaud F, Bibeau F, Fléjou JF, André T, Svrcek M, Duval A.

JAMA Oncol. 2019 Apr 1;5(4):551-555. doi: 10.1001/jamaoncol.2018.4942.

PMID:
30452494
4.

Prevalence and clinicopathological characteristics of mismatch repair-deficient colorectal carcinoma in early onset cases as compared with late-onset cases: a retrospective cross-sectional study in Northeastern Iran.

Goshayeshi L, Ghaffarzadegan K, Khooei A, Esmaeilzadeh A, Rahmani Khorram M, Mosannen Mozaffari H, Kiani B, Hoseini B.

BMJ Open. 2018 Aug 30;8(8):e023102. doi: 10.1136/bmjopen-2018-023102.

5.

Development of patient-derived orthotopic xenografts from metastatic colorectal cancer in nude mice.

Roque-Lima B, Roque CCTA, Begnami MD, Peresi P, Lima ENP, Mello CAL, Coimbra FJ, Chojniak R, Goss Santos T.

J Drug Target. 2019 Nov;27(9):943-949. doi: 10.1080/1061186X.2018.1509983. Epub 2018 Sep 5.

PMID:
30088428
6.

Molecular characteristics of colorectal cancer in a Middle Eastern population in a single institution.

Ibrahim T, Saer-Ghorra C, Trak-Smayra V, Nadiri S, Yazbeck C, Baz M, Kattan JG.

Ann Saudi Med. 2018 Jul-Aug;38(4):251-259. doi: 10.5144/0256-4947.2018.245.

7.

Prognostic values of detecting MSI phenotypes in colorectal carcinoma by immunohistochemical method compared to molecular investigation.

Trabelsi M, Farah F, Blel A, Jaafoura MH, Kharrat M, Rammeh S.

Tunis Med. 2017 Dec;95(12):229-236.

8.

Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome.

Cloyd JM, Chun YS, Ikoma N, Vauthey JN, Aloia TA, Cuddy A, Rodriguez-Bigas MA, Nancy You Y.

J Gastrointest Cancer. 2018 Mar;49(1):93-96. doi: 10.1007/s12029-017-0040-9.

PMID:
29238914
9.

Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.

Cohen R, Buhard O, Cervera P, Hain E, Dumont S, Bardier A, Bachet JB, Gornet JM, Lopez-Trabada D, Dumont S, Kaci R, Bertheau P, Renaud F, Bibeau F, Parc Y, Vernerey D, Duval A, Svrcek M, André T.

Eur J Cancer. 2017 Nov;86:266-274. doi: 10.1016/j.ejca.2017.09.022. Epub 2017 Oct 19.

PMID:
29055842
10.

Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer.

Tóth C, Sükösd F, Valicsek E, Herpel E, Schirmacher P, Renner M, Mader C, Tiszlavicz L, Kriegsmann J.

Int J Mol Med. 2017 Nov;40(5):1457-1465. doi: 10.3892/ijmm.2017.3136. Epub 2017 Sep 14.

11.

ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis.

Fan J, Huang B, Yang X, Yang M, He J, Nie X.

Diagn Pathol. 2017 Sep 18;12(1):68. doi: 10.1186/s13000-017-0645-0.

12.

The Relationship Between Mismatch Repair Deficiency and PD-L1 Expression in Breast Carcinoma.

Mills AM, Dill EA, Moskaluk CA, Dziegielewski J, Bullock TN, Dillon PM.

Am J Surg Pathol. 2018 Feb;42(2):183-191. doi: 10.1097/PAS.0000000000000949.

PMID:
28914717
13.

Thyroid cancer in a patient with Lynch syndrome - case report and literature review.

Fazekas-Lavu M, Parker A, Spigelman AD, Scott RJ, Epstein RJ, Jensen M, Samaras K.

Ther Clin Risk Manag. 2017 Jul 21;13:915-918. doi: 10.2147/TCRM.S121812. eCollection 2017.

14.

Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.

Hashmi AA, Ali R, Hussain ZF, Faridi N, Khan EY, Bakar SMA, Edhi MM, Khan M.

World J Surg Oncol. 2017 Jun 26;15(1):116. doi: 10.1186/s12957-017-1158-8.

15.

Primary multiple tumor with affection of the thyroid gland, uterus, urinary bladder, mammary gland and other organs.

Romaniuk А, Lyndin M, Smiyanov V, Sikora V, Rieznik A, Kuzenko Y, Budko H, Moskalenko Y, Karpenko L, Sikora V, Gladchenko O.

Pathol Res Pract. 2017 May;213(5):574-579. doi: 10.1016/j.prp.2017.01.003. Epub 2017 Jan 19.

PMID:
28214212
16.

Extent of field change in colorectal cancers with BRAF mutation.

Poh A, Chang HS, Tan KY, Sam XX, Khoo A, Choo SN, Nga ME, Wan WK.

Singapore Med J. 2018 Mar;59(3):139-143. doi: 10.11622/smedj.2017012. Epub 2017 Feb 17. Review.

17.

Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry.

Jung J, Kang Y, Lee YJ, Kim E, Ahn B, Lee E, Kim JY, Lee JH, Lee Y, Kim CH, Chae YS.

J Pathol Transl Med. 2017 Mar;51(2):129-136. doi: 10.4132/jptm.2016.12.09. Epub 2017 Feb 14.

18.

[Characteristics and Outcomes of Treatment in Patients with Stage IV Colorectal Cancer with Mismatch Repair Deficiency].

Ishibashi K, Chika N, Suzuki O, Ito T, Amano K, Kumamoto K, Fukuchi M, Kumagai Y, Mochiki E, Ishida H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1711-1714. Japanese.

PMID:
28133107
19.

Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair.

Alex AK, Siqueira S, Coudry R, Santos J, Alves M, Hoff PM, Riechelmann RP.

Clin Colorectal Cancer. 2017 Sep;16(3):228-239. doi: 10.1016/j.clcc.2016.11.001. Epub 2016 Nov 26.

PMID:
28063788
20.

Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report.

Gohda Y, Noguchi R, Horie T, Igari T, Nakamura H, Ohta Y, Yamaguchi K, Ikenoue T, Hatakeyama S, Yusa N, Furukawa Y, Yano H.

BMC Med Genet. 2016 Dec 9;17(1):94.

Supplemental Content

Loading ...
Support Center